BeiGene, Ltd. (6160.HK)

HKD 105.9

(-1.4%)

Eps Summary of BeiGene, Ltd.

  • BeiGene, Ltd.'s latest annual eps in 2023 was -8.45 USD , up 56.38% from previous year.
  • BeiGene, Ltd.'s latest quarterly eps in 2024 Q2 was -0.09 USD , down -505.26% from previous quarter.
  • BeiGene, Ltd. reported an annual eps of -1.49 USD in 2022, down -27.35% from previous year.
  • BeiGene, Ltd. reported an annual eps of -1.17 USD in 2021, up 20.41% from previous year.
  • BeiGene, Ltd. reported a quarterly eps of -0.19 USD for 2024 Q1, up 29.63% from previous quarter.
  • BeiGene, Ltd. reported a quarterly eps of -0.27 USD for 2023 Q4, down -268.75% from previous quarter.

Annual Eps Chart of BeiGene, Ltd. (2023 - 2013)

Historical Annual Eps of BeiGene, Ltd. (2023 - 2013)

Year Eps Eps Growth
2023 -8.45 USD 56.38%
2022 -1.49 USD -27.35%
2021 -1.17 USD 20.41%
2020 -1.47 USD -20.49%
2019 -1.22 USD -31.18%
2018 -0.93 USD -481.25%
2017 -0.16 USD 30.43%
2016 -0.23 USD -64.29%
2015 -0.14 USD -424.34%
2014 -0.03 USD -144.95%
2013 -0.01 USD 0.0%

Peer Eps Comparison of BeiGene, Ltd.

Name Eps Eps Difference
Uni-Bio Science Group Limited 0.01 HKD 76226.126%
CK Life Sciences Int'l., (Holdings) Inc. 0.00 HKD 469544.444%